Dissolution of intraocular fibrinous exudate by streptokinase

G. M. Cherfan, A. El Maghraby, K. F. Tabbara, Y. Nasr, H. Hassan

Research output: Contribution to journalArticle

Abstract

In a prospective, open, pilot study, the authors evaluated the effects of intraocular injection of streptokinase on intraocular fibrin. The study was composed of nine patients in whom fibrinous exudate developed after pars plana vitrectomy. There were seven male and two female patients with a mean age of 44 years (range, 27 to 65 years). Fibrinous exudates were seen 1 to 22 days after surgery with obstruction of the view of the posterior segment. Each patient received a single intraocular injection of 1000 IU of purified streptokinase. Four hours after the streptokinase injection, complete dissolution of the fibrin was noted in each patient. There were no clinically detectable adverse effects from the intraocular administration of streptokinase. Streptokinase may be considered in the dissolution of intractable fibrinous exudates after vitrectomy.

Original languageEnglish (US)
Pages (from-to)870-874
Number of pages5
JournalOphthalmology
Volume98
Issue number6
StatePublished - 1991
Externally publishedYes

Fingerprint

Streptokinase
Exudates and Transudates
Intraocular Injections
Vitrectomy
Fibrin
Temazepam
Ambulatory Surgical Procedures
Injections

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Cherfan, G. M., El Maghraby, A., Tabbara, K. F., Nasr, Y., & Hassan, H. (1991). Dissolution of intraocular fibrinous exudate by streptokinase. Ophthalmology, 98(6), 870-874.

Dissolution of intraocular fibrinous exudate by streptokinase. / Cherfan, G. M.; El Maghraby, A.; Tabbara, K. F.; Nasr, Y.; Hassan, H.

In: Ophthalmology, Vol. 98, No. 6, 1991, p. 870-874.

Research output: Contribution to journalArticle

Cherfan, GM, El Maghraby, A, Tabbara, KF, Nasr, Y & Hassan, H 1991, 'Dissolution of intraocular fibrinous exudate by streptokinase', Ophthalmology, vol. 98, no. 6, pp. 870-874.
Cherfan GM, El Maghraby A, Tabbara KF, Nasr Y, Hassan H. Dissolution of intraocular fibrinous exudate by streptokinase. Ophthalmology. 1991;98(6):870-874.
Cherfan, G. M. ; El Maghraby, A. ; Tabbara, K. F. ; Nasr, Y. ; Hassan, H. / Dissolution of intraocular fibrinous exudate by streptokinase. In: Ophthalmology. 1991 ; Vol. 98, No. 6. pp. 870-874.
@article{b181df2021784716bc78828cb4b79e1e,
title = "Dissolution of intraocular fibrinous exudate by streptokinase",
abstract = "In a prospective, open, pilot study, the authors evaluated the effects of intraocular injection of streptokinase on intraocular fibrin. The study was composed of nine patients in whom fibrinous exudate developed after pars plana vitrectomy. There were seven male and two female patients with a mean age of 44 years (range, 27 to 65 years). Fibrinous exudates were seen 1 to 22 days after surgery with obstruction of the view of the posterior segment. Each patient received a single intraocular injection of 1000 IU of purified streptokinase. Four hours after the streptokinase injection, complete dissolution of the fibrin was noted in each patient. There were no clinically detectable adverse effects from the intraocular administration of streptokinase. Streptokinase may be considered in the dissolution of intractable fibrinous exudates after vitrectomy.",
author = "Cherfan, {G. M.} and {El Maghraby}, A. and Tabbara, {K. F.} and Y. Nasr and H. Hassan",
year = "1991",
language = "English (US)",
volume = "98",
pages = "870--874",
journal = "Ophthalmology",
issn = "0161-6420",
publisher = "Elsevier Inc.",
number = "6",

}

TY - JOUR

T1 - Dissolution of intraocular fibrinous exudate by streptokinase

AU - Cherfan, G. M.

AU - El Maghraby, A.

AU - Tabbara, K. F.

AU - Nasr, Y.

AU - Hassan, H.

PY - 1991

Y1 - 1991

N2 - In a prospective, open, pilot study, the authors evaluated the effects of intraocular injection of streptokinase on intraocular fibrin. The study was composed of nine patients in whom fibrinous exudate developed after pars plana vitrectomy. There were seven male and two female patients with a mean age of 44 years (range, 27 to 65 years). Fibrinous exudates were seen 1 to 22 days after surgery with obstruction of the view of the posterior segment. Each patient received a single intraocular injection of 1000 IU of purified streptokinase. Four hours after the streptokinase injection, complete dissolution of the fibrin was noted in each patient. There were no clinically detectable adverse effects from the intraocular administration of streptokinase. Streptokinase may be considered in the dissolution of intractable fibrinous exudates after vitrectomy.

AB - In a prospective, open, pilot study, the authors evaluated the effects of intraocular injection of streptokinase on intraocular fibrin. The study was composed of nine patients in whom fibrinous exudate developed after pars plana vitrectomy. There were seven male and two female patients with a mean age of 44 years (range, 27 to 65 years). Fibrinous exudates were seen 1 to 22 days after surgery with obstruction of the view of the posterior segment. Each patient received a single intraocular injection of 1000 IU of purified streptokinase. Four hours after the streptokinase injection, complete dissolution of the fibrin was noted in each patient. There were no clinically detectable adverse effects from the intraocular administration of streptokinase. Streptokinase may be considered in the dissolution of intractable fibrinous exudates after vitrectomy.

UR - http://www.scopus.com/inward/record.url?scp=0025827999&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025827999&partnerID=8YFLogxK

M3 - Article

C2 - 1866139

AN - SCOPUS:0025827999

VL - 98

SP - 870

EP - 874

JO - Ophthalmology

JF - Ophthalmology

SN - 0161-6420

IS - 6

ER -